Hemp Is Legal. So Why Does the FDA Still Regulate CBD?

Many people assume that when hemp became federally legal, CBD products automatically became fully approved and regulated for everyday sale. That is not exactly how federal law works.

The 2018 Farm Bill created a legal pathway for hemp, but it did not remove the U.S. Food and Drug Administration’s authority over CBD products sold to consumers. A CBD product may come from federally lawful hemp and still raise FDA concerns if it is mislabeled, marketed with disease claims, added to food in a way FDA does not allow, or sold without proper safety support.

This article explains the difference between hemp legality and FDA oversight, why FDA warning letters matter, how CBD labeling and health claims are regulated, and why third-party testing remains important for consumers.

For broader legal context, read CBD and Cannabis Laws Explained. You may also want to review What Makes Hemp Flower Federally Legal? and Understanding THC Limits in Hemp Products.

The Short Answer: Hemp Legalization and FDA Regulation Are Different Things

Hemp legalization and FDA product regulation are related, but they are not the same thing.

Agency	Main Role	Why It Matters
USDA	Oversees hemp production programs	Regulates hemp cultivation and compliance programs.
FDA	Oversees many consumer products	Regulates safety, labeling, marketing claims, drugs, foods, cosmetics, and supplements.
FTC	Oversees advertising practices	Can act against deceptive advertising or unsupported claims.
State Agencies	Regulate state-level hemp and CBD rules	May impose additional restrictions on sales, labeling, product types, or THC limits.

The USDA Domestic Hemp Production Program explains the federal hemp production framework. The FDA’s CBD consumer guidance explains how the agency views cannabis-derived products, including CBD.

How the 2018 Farm Bill Changed Hemp Laws

The Agricultural Improvement Act of 2018, commonly called the 2018 Farm Bill, changed federal hemp law by creating a legal distinction between hemp and marijuana.

Under the 2018 framework, hemp generally means cannabis containing no more than 0.3% Delta-9 THC on a dry-weight basis. The law helped remove qualifying hemp from the federal Controlled Substances Act and created a pathway for commercial hemp production.

You can review the federal legislative record through Congress.gov’s 2018 Farm Bill page.

However, hemp legalization did not mean that every hemp-derived CBD product became automatically lawful in every form. Congress preserved FDA authority over products containing cannabis-derived ingredients, including CBD.

What Role Does the FDA Play in CBD Regulation?

The FDA’s role is consumer product oversight. The agency evaluates issues such as safety, labeling, manufacturing practices, health claims, and whether a product is being marketed as a drug, food, dietary supplement, cosmetic, or animal product.

Product Category	FDA Concern
CBD foods	Whether CBD can lawfully be added to food products.
CBD dietary supplements	Whether CBD fits existing supplement rules.
CBD cosmetics	Safety, labeling, and marketing claims.
CBD drugs	Drug approval and disease-treatment claims.
CBD pet products	Animal safety and unapproved therapeutic claims.

The FDA has approved one prescription CBD drug product, Epidiolex, for specific seizure-related conditions. The agency has not approved most over-the-counter CBD products sold in the general marketplace.

Why a Legal Hemp Product Can Still Violate FDA Rules

A product can be hemp-derived and still create FDA compliance issues. This is one of the most important distinctions for consumers and businesses to understand.

Product Situation	Hemp Law Issue	FDA Issue
CBD oil made from compliant hemp	May meet hemp requirements	Still must avoid improper claims and labeling problems.
CBD product claiming to treat cancer	May be hemp-derived	Likely an unapproved drug claim.
CBD gummy marketed as a dietary supplement	May be hemp-derived	FDA has said current food and supplement pathways are not appropriate for CBD.
CBD product with inaccurate cannabinoid content	May be hemp-derived	May raise labeling and consumer protection concerns.

This is why CBD compliance is not just about THC limits. It also involves labeling, testing, marketing, safety, and transparency.

FDA Rules on CBD Health Claims

FDA warning letters show that health and disease claims are one of the agency’s biggest concerns in the CBD marketplace.

Companies can create serious compliance problems when they claim that CBD products diagnose, treat, cure, or prevent diseases without FDA approval. The FDA maintains a public page of warning letters for cannabis-derived products, including CBD and Delta-8 THC products.

Common warning-letter issues include claims related to pain, anxiety, cancer, Alzheimer’s disease, opioid addiction, pet conditions, and other medical concerns.

How the FDA Views CBD in Foods and Dietary Supplements

CBD foods and dietary supplements remain one of the most unresolved areas of federal CBD regulation.

In 2023, the FDA announced that existing regulatory frameworks for foods and dietary supplements are not appropriate for CBD and stated that a new regulatory pathway is needed. The agency also denied citizen petitions asking it to allow CBD products to be marketed as dietary supplements under the existing framework.

You can read the FDA’s statement here: FDA Concludes Existing Frameworks for Foods and Supplements Are Not Appropriate for CBD.

For consumers, this means the CBD marketplace is still developing. Products may be widely available, but that does not mean every CBD food, gummy, capsule, or supplement-style product has been reviewed or approved by FDA.

CBD Labeling and Consumer Protection

CBD labels matter because consumers rely on them to understand what they are buying. A clear label should help identify product type, cannabinoid content, serving information, ingredients, warnings, batch details, and company information.

Labeling problems can include:

• Incorrect CBD amounts
• Missing THC information
• Unsupported health claims
• Unclear serving sizes
• Missing batch or lot numbers
• Confusing product descriptions

For a deeper look at product transparency, read CBD Labeling Requirements Explained and Why Third-Party Testing Matters for CBD and Hemp Products.

Why Third-Party Testing Matters More Than Ever

Because CBD regulation remains complicated, third-party testing is one of the most useful consumer protection tools available.

A Certificate of Analysis, often called a COA, can help verify:

• CBD content
• Delta-9 THC levels
• Other cannabinoids
• Batch number
• Testing date
• Pesticide screening
• Heavy metal testing
• Microbial testing

Consumers can review Green Nursery’s COAs and lab reports before purchasing. You can also browse lab-tested CBD products and the CBD Flower Collection.

For more help reading test results, visit How to Read a CBD Flower Lab Report and Hemp Testing for Pesticides and Heavy Metals.

FDA Warning Letters and What They Reveal About Industry Compliance

FDA warning letters are useful because they show the kinds of CBD marketing practices the agency continues to scrutinize.

Common FDA Concern	Why It Matters
Disease-treatment claims	May cause consumers to rely on unapproved products.
Misleading labeling	Can make it harder for consumers to understand what they are buying.
Unapproved drug claims	Products claiming to treat disease generally require FDA approval.
CBD in foods or supplements	FDA has said existing pathways are not appropriate for CBD.
Delta-8 THC products	FDA has raised concerns about safety, labeling, and marketing.

The warning-letter record reinforces a simple point: CBD companies should be careful with claims, labels, and product transparency.

What This Means for Consumers

Consumers do not need to become regulatory experts, but they should know how to spot better CBD products.

Before purchasing CBD, ask:

• Does the company provide current COAs?
• Does the product label clearly identify CBD content?
• Does the product avoid unrealistic medical claims?
• Does the company provide clear contact information?
• Are ingredients, serving sizes, and warnings easy to understand?
• Does the company explain its testing and quality standards?

Green Nursery customers can review COAs and lab reports, read customer reviews, visit the FAQ page, learn more about Green Nursery, and explore CBD products.

What We Know vs. What Is Still Uncertain

Enacted Law

• The 2018 Farm Bill created the modern federal hemp framework.
• FDA retains authority over hemp-derived products, including CBD products.
• Companies cannot market CBD products as disease treatments without appropriate FDA approval.
• The FDA has approved one prescription CBD drug product, but most retail CBD products are not FDA-approved drugs.

Agency Guidance

• FDA continues to warn consumers about safety, quality, and labeling concerns in the CBD marketplace.
• FDA has said existing food and dietary supplement frameworks are not appropriate for CBD.
• FDA continues issuing warning letters to companies marketing cannabis-derived products in ways the agency considers problematic.

Proposed Legislation

• Congress may continue considering future hemp and cannabinoid reforms.
• A future CBD regulatory pathway could affect labeling, testing, manufacturing, age restrictions, product formats, or claims.
• Proposed legislation should not be treated as current law unless passed by Congress and signed into law.

Industry Expectations

• Many responsible CBD companies expect greater emphasis on testing and documentation.
• More standardized labeling may become important as regulation evolves.
• Consumers are likely to place increasing value on transparency, COAs, and clear product information.

How Future FDA Decisions Could Affect the Hemp Industry

Future FDA or congressional action could significantly affect the CBD marketplace. Possible future changes could involve CBD-specific labeling standards, manufacturing rules, serving-size limits, age restrictions, testing expectations, or a new pathway for ingestible CBD products.

For manufacturers and retailers, clearer rules could create more predictable compliance standards. For consumers, stronger standards could make it easier to compare products and identify trustworthy companies.

For now, the best approach is to separate what is already law from what remains under discussion. FDA oversight exists today, but the long-term regulatory framework for many CBD products remains unfinished.

Frequently Asked Questions About FDA and CBD

Does the FDA regulate CBD?

Yes. FDA regulates many aspects of CBD product safety, labeling, marketing, health claims, and product categories such as foods, drugs, cosmetics, and supplements.

Did the 2018 Farm Bill legalize all CBD products?

No. The 2018 Farm Bill legalized qualifying hemp under federal law, but it did not eliminate FDA oversight of CBD products.

Is CBD FDA approved?

The FDA has approved one prescription CBD drug product. Most over-the-counter CBD products have not been approved by FDA as drugs.

Can CBD be marketed as a dietary supplement?

FDA has stated that existing food and dietary supplement frameworks are not appropriate for CBD and has denied petitions seeking rulemaking to allow CBD as a dietary supplement under the existing framework.

What is an FDA warning letter?

An FDA warning letter is a formal notice identifying violations or concerns the agency has found. CBD warning letters often involve disease claims, unapproved drug claims, or other consumer protection issues.

Can CBD companies make health claims?

CBD companies should not claim that products diagnose, treat, cure, or prevent diseases unless the product has gone through the required FDA approval process.

Does FDA regulate hemp farms?

Hemp cultivation is primarily overseen through USDA and state hemp programs. FDA becomes more relevant when hemp-derived ingredients are used in consumer products.

Why do COAs matter if FDA regulates CBD?

COAs help consumers verify cannabinoid content, THC levels, batch information, and contaminant testing. They are especially important because the retail CBD marketplace remains uneven.

Does FDA regulate CBD flower?

FDA authority depends on how a product is marketed and used. Hemp flower may also be subject to federal hemp rules, state laws, labeling requirements, and other regulations.

Will CBD regulations change?

Possibly. FDA has called for a new regulatory pathway for CBD, and Congress may continue considering future hemp and cannabinoid reforms.

Final Takeaway

The biggest lesson is simple: hemp legality and FDA oversight are different things.

The 2018 Farm Bill helped create the modern hemp industry, but FDA still plays a major role in how CBD products are marketed, labeled, manufactured, and presented to consumers.

For consumers, the safest approach is to choose transparent companies, avoid products making unrealistic medical claims, review current COAs, and learn how CBD labeling and testing work.

To keep learning, visit CBD and Cannabis Laws Explained, read Why Third-Party Testing Matters, explore CBD products, and review Green Nursery’s COAs and lab reports.

Disclaimer: This article is for educational and informational purposes only and is not legal or medical advice. CBD laws, FDA policies, enforcement priorities, and product requirements may change over time and may vary by jurisdiction.